Varian Medical (NYSE:VAR) said today that it stands behind its initial $1.28 billion bid to acquire Sirtex Medical (ASX:SRX) in the wake of a $1.41 billion counter offer from China’s CDH Investments.
The unsolicited bid from CDH Investments came in at a 20% premium on Varian’s A$28-per-share offer, prompting Sirtex to reconsider a merger that already has approval from U.S. antitrust authorities and the German Federal Cartel Office.
Get the full story at our sister site, Drug Delivery News.
The post Varian stands on $1.28B offer for Sirtex appeared first on MassDevice.
from MassDevice https://ift.tt/2s3Z2GV
Cap comentari:
Publica un comentari a l'entrada